BARD1 Life Sciences Company
BARD1 Life Sciences Ltd is an Australian life sciences company focused on developing and commercialising non-invasive diagnostic tests
Technology:
Biomarkers of Female Cancers
Headquarters:
Nedlands, Western Australia, Australia
Acquisitions Number:
1
Funding Status:
IPO
Founded Date:
01-01-1983
Last Funding Type:
Post-IPO Equity
Investors Number:
1
Last Funding Date:
2021-07-23
Estimated Revenue:
Less than $1M
Employee Number:
11-50
Total Funding:
$18,576,901
Industry:
Menstrual Health